Bioarray & IVFSpain present clinical outcome of PGS by NGS: 64 babies since 2015

Blastocyst biopsy for PGS

Vanessa Penacho PhD, Bioarray’s RD

Bioarray genetic lab and IVF-Spain fertility clinic present at ESHRE meeting (Helsinki, July 3-6) outcome of PGS using NGS: 64 babies and 53 ongoing pregnancies

ALICANTE, SPAIN, June 29, 2016 / — Bioarray, S.L., IVF SPAIN S.L. and iGLS will present clinical outcomes of IVF treatments with PGS by NGS, after two years providing this genetic test as part of a cooperation supported in a framework agreement. The upcoming Annual Meeting of ESHRE, European Society of Human Reproduction and Embryology (Helsinki, 3 to 6 July) will be the chosen context for this release, being a

Article source: